238 related articles for article (PubMed ID: 24800782)
1. An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer.
Xiong BH; Cheng Y; Ma L; Zhang CQ
Cancer Invest; 2014 Jul; 32(6):272-84. PubMed ID: 24800782
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials.
Xiong B; Ma L; Cheng Y; Zhang C
Eur J Surg Oncol; 2014 Oct; 40(10):1321-30. PubMed ID: 25239442
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
5. Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis.
Yang Y; Yin X; Sheng L; Xu S; Dong L; Liu L
Sci Rep; 2015 Aug; 5():12850. PubMed ID: 26242393
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.
Liao Y; Yang ZL; Peng JS; Xiang J; Wang JP
J Gastroenterol Hepatol; 2013 May; 28(5):777-82. PubMed ID: 23425049
[TBL] [Abstract][Full Text] [Related]
7. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
8. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy versus none for resectable gastric cancer.
Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
Cochrane Database Syst Rev; 2007 Apr; (2):CD005047. PubMed ID: 17443566
[TBL] [Abstract][Full Text] [Related]
10. The efficiency and safety of trastuzumab for advanced gastric and gastroesophageal cancer: a meta-analysis of five randomized controlled trials.
Xiong B; Ma L; Huang W; Luo H; Zeng Y; Tian Y
Growth Factors; 2016 Dec; 34(5-6):187-195. PubMed ID: 27921577
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy brings more survival benefits than postoperative chemotherapy for resectable gastric cancer: a Meta-analysis of randomized controlled trials.
Hu Y; Hu D; Li W; Yu X
J BUON; 2019; 24(1):201-214. PubMed ID: 30941971
[TBL] [Abstract][Full Text] [Related]
12. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.
Miao ZF; Liu XY; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Xu H; Xu HM
BMC Cancer; 2018 Jan; 18(1):118. PubMed ID: 29385994
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.
Li W; Qin J; Sun YH; Liu TS
World J Gastroenterol; 2010 Nov; 16(44):5621-8. PubMed ID: 21105197
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of neoadjuvant chemotherapy for resectable cancer of the gastric and gastroesophageal junction: a meta-analysis.
Jiang L; Yang KH; Guan QL; Chen Y; Zhao P; Tian JH
J Clin Gastroenterol; 2015; 49(5):387-94. PubMed ID: 25144898
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials.
Xu AM; Huang L; Liu W; Gao S; Han WX; Wei ZJ
PLoS One; 2014; 9(1):e86941. PubMed ID: 24497999
[TBL] [Abstract][Full Text] [Related]
16. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.
Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R
Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369
[TBL] [Abstract][Full Text] [Related]
17. Does neoadjuvant chemotherapy improve outcomes for patients with gastric cancer?
Misra S; Pedroso FE; DiPasco PJ; Solomon NL; Gennis E; Franceschi D; Ardalan B; Koniaris LG
J Surg Res; 2012 Dec; 178(2):623-31. PubMed ID: 22682528
[TBL] [Abstract][Full Text] [Related]
18. [Meta analysis of clinical effectiveness of neoadjuvant chemotherapy for gastric cancer].
He LF; Yang KH; Tian JH; Bai ZG
Ai Zheng; 2008 Apr; 27(4):407-12. PubMed ID: 18423128
[TBL] [Abstract][Full Text] [Related]
19. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
[TBL] [Abstract][Full Text] [Related]
20. WITHDRAWN: Neoadjuvant chemotherapy versus none for resectable gastric cancer.
Wu AW; Xu GW; Wang HY; Ji JF; Tang JL
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005047. PubMed ID: 17943834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
